Skip Navigation


Age and Ageing Advance Access originally published online on August 5, 2008
Age and Ageing 2008 37(5):497-499; doi:10.1093/ageing/afn147
This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
37/5/497    most recent
afn147v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mitchell, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitchell, A. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © The Author 2008. Published by Oxford University Press on behalf of the British Geriatrics Society.

Commentary

Is it time to separate subjective cognitive complaints from the diagnosis of mild cognitive impairment?

Alex J. Mitchell

Leicester General Hospital, Leicester LE5 4PW and Honorary Senior Lecturer in Liaison Psychiatry, Department of Cancer & Molecular Medicine, Leicester Royal Infirmary LE1 5WW, UK

Address correspondence to: A.J. Mitchell. Tel: (+44) 0116 225 6218; Fax: (+44) 0116 2951951. Email: ajm80{at}le.ac.uk


    Abstract
 Top
 Abstract
 How many health elderly...
 How is the prevalence...
 How is the prognosis...
 How should SCC be...
 Conclusion
 Key points
 References
 
Subjective cognitive complaints (SCC) are currently considered to be a core feature of mild cognitive impairment (MCI). Yet the implications of including or excluding subjective complaints has not been previously considered. The key questions are how many health people complain of SCC compared to those with MCI? How is the epidemiology of MCI affected by the requirement for SCC? How is the prognosis of MCI influenced by SCC? and how should SCC be defined and measured? Findings to date suggest that subjective complaints are one of many variables that comprise risk in individuals with MCI. Individuals who do not have subjective complaints and might not qualify under current definitions of MCI may still have a disorder that is of clinical significance. Despite a close association, SCC may be neither necessary nor sufficient for a diagnosis of either MCI or dementia.

Keywords: subjective memory complaints, mild cognitive impairment, dementia, elderly


Subjective cognitive complaints (SCC, also known as subjective memory complaints) refer to everyday concerns cited by people both with and without objective evidence of memory impairment. Such complaints are very common. It was found that 30% of the unimpaired elderly report that they have ‘trouble remembering things that have happened recently’ and a similar number have ‘trouble remembering where belongings are kept’ [1]. From the clinical perspective, there is likely to be an important difference between those who agree that they have slight difficulty on direct questioning and those who actively seek help for memory complaints.

Lately, the importance of SCC has been emphasised by its inclusion as a core feature of mild cognitive impairment (MCI) in recent consensus reports [2, 3]. Despite this apparent consensus, their inclusion remains controversial and many research groups have not used SCC when diagnosing MCI. One issue is that there is no single optimal method to elicit SCC; rather there are at least 20 competing subjective memory questionnaires, few of which have adequate validation. An even more fundamental issue is that whilst many studies document a relationship between subjective and objective memory complaints, many have failed to find such a relationship (for review see [4]). A further complication is that SCC can represent the concerns of a patient or a close family member. This might prove to be important as preliminary studies have found that the association between subjective ratings and future cognitive decline is stronger for informant rather than patient complaints [5]. Collectively, these issues have led to uncertainty about the clinical significance of patient-reported SCC and a question mark over the use of SCC in defining MCI. In order to clarify the significance of SCC in diagnosing MCI, four questions which may help disentangle this complex issue are suggested: How many health elderly people compared to those with MCI complain of SCC? How is the prevalence of MCI affected by the inclusion of SCC in the definition? How is the prognosis of MCI affected by inclusion of SCC? How should SCC best be defined?


    How many health elderly people complain of SCC compared to those with MCI?
 Top
 Abstract
 How many health elderly...
 How is the prevalence...
 How is the prognosis...
 How should SCC be...
 Conclusion
 Key points
 References
 
Several studies have examined the rate of memory difficulties in selected community samples, but few have done so in comparison to those with known MCI [4]. A complication is that the rate of SCC is not stable but varies significantly over time. A second complication is that the rate of SCC is strongly influenced by age such that the rate in those aged under 65 is about 20%, but this quickly rises to about 90% in those over 85 [6]. One of the best estimates of SCC comes from Crooks and colleagues (2001) who studied a community sample aged 65 and older using the single question ‘Do you have severe memory problems?’ [7] It was found that 38.6% of those with dementia, 12.4% of those with loosely defined MCI and 1% of non-cognitively impaired controls reported severe SCC. Clearly, if one required SCC as part of the criteria for MCI then by definition all such individuals would have SCC.


    How is the prevalence of MCI affected by SCC?
 Top
 Abstract
 How many health elderly...
 How is the prevalence...
 How is the prognosis...
 How should SCC be...
 Conclusion
 Key points
 References
 
Ganguli and colleagues examined how many cases with cognitive complaints satisfied the criteria for MCI. Out of 1,248 individuals in the Steel Valley study, 36.7% had SCC but only 3.2% met full criteria for MCI [8]. Yet without the requirement for SCC, 6.3% met criteria for MCI. In the Iowa Established Populations for Epidemiologic Studies of the Elderly consisting of 3,673 persons aged 65 or over, Purser et al. (2006) found that 8.9% met strict criteria for MCI compared to 14% who met criteria if SCC were not required [9]. Luck and colleagues (2007) recently examined the frequency of MCI in a primary care sample [10]. The prevalence was 15.4% for strict criteria and 25.2% for modified criteria. These studies suggest that the effect of requiring SCC is to reduce the rate of MCI by 30–50%, so that the overall prevalence is very close to that of dementia itself. Yet, this does not necessarily mean that inclusion of SCC is redundant, particularly if the prognosis of MCI is strongly influenced by the presence of SCC.


    How is the prognosis of MCI affected by inclusion of SCC?
 Top
 Abstract
 How many health elderly...
 How is the prevalence...
 How is the prognosis...
 How should SCC be...
 Conclusion
 Key points
 References
 
Regardless of any effect on the prevalence of MCI, most clinicians want to know whether the risk of conversion to dementia is affected. It has been suggested that SCC may have special significance in that they may anticipate future decline above and beyond baseline cognitive testing. Two adequately powered studies have found little or no influence of SCC on progression in those with no cognitive impairment at baseline [9, 11]. In those with memory complaints and objective evidence of decline, rates of conversion to dementia are elevated even when the cause of cognitive decline is unknown [12]. More recent studies also appear to show that SCC adversely influences future decline in those with baseline MCI. For example, Fisk and colleagues examined the outcome of MCI in the 5 year Canadian Study of Health and Aging (CSHA) [13]. There was a hierarchal risk of progression to dementia: 71.4% of those meeting all criteria for amnestic MCI converted compared to 68% in those where deficits in function were allowed, 56% where no SCC were required and 56% where neither was required. Indirect evidence also comes from other long-term studies where SCC were specifically not required in the definition of MCI. Here the progression rate to dementia tends to be much lower than expected.

An important finding was recently reported from participants in the Kungsholmen project, interviewed 3 years before developing dementia [14]. One-third reported neither memory complaints nor objective cognitive deficits on the Mini-Mental State Examination (MMSE) 3 years before diagnosis. A further 16% had no complaints but evidence of decline on the MMSE. Thus, although there is a definite association with underlying cognitive disorders, subject complaints are neither necessary nor sufficient for a diagnosis of either MCI or dementia or the prediction of later dementia.


    How should SCC be defined?
 Top
 Abstract
 How many health elderly...
 How is the prevalence...
 How is the prognosis...
 How should SCC be...
 Conclusion
 Key points
 References
 
If SCC do have either diagnostic or prognostic significance, what is the best way to elicit such complaints and are all complaints of equal significance? In other words, should all possible complaints be included under the rubric of MCI or only certain ‘high-risk’ complaints? Grut et al (1993) examined the significance of ‘slight’ versus ‘marked’ SCC [15]. Marked deficits were more discriminating of those with MCI versus without MCI occurring in 19% versus 5% compared with 30 and 28%, for ‘slight’ deficits. Clarnette and colleagues (2001) compared 97 individuals with and 38 without SCC (regardless of MCI status) [16]. From a small list of complaints, the most discriminating was word-finding difficulty. This hints that not all types of cognitive complaints are of equal significance and echoes the findings of neuropsychological studies examining the significance of specific types of cognitive test in diagnosing dementia and MCI.


    Conclusion
 Top
 Abstract
 How many health elderly...
 How is the prevalence...
 How is the prognosis...
 How should SCC be...
 Conclusion
 Key points
 References
 
From this data, it is clear that the relationship between subjective and objective cognitive impairments is complex. Looked at categorically, there are four subgroups of people depending on their subjective and objective complaints (both, neither, subjective aloneand objective alone). Lautenschlager and colleagues found that the proportion in each of these categories was 10.6, 40.1, 46 and 3.4%, respectively [17]. Risk of progression appears to be ranked as follows: both> objective alone> subjective alone> neither. Yet perceived forgetfulness is not always a sinister finding. In the Maastricht Aging Study, 30% of those with memory difficulties had little or no impairment in activities of daily living and about 40% were not (or hardly) worried about their forgetfulness. It seems likely that in the absence of any other clinically concerning finding, isolated SCC are unlikely to be clinically significant. In association with other features, however, they do have added value (for prediction of later dementia) but at a cost of reducing the proportion of people who can be labelled with MCI. In statistical terms, they increase the specificity and positive predictive value but reduce the sensitivity and negative predictive value. There is also an implication for screening for dementia where a combination of subjective and objective tests could be more useful than either one used alone [18, 19]. SCC may be useful diagnostically because simple questions concerning everyday cognitive abilities are more acceptable to patients than lengthy objective testing. Regarding the diagnosis of MCI, it might be useful to redefine the core criteria for MCI on the basis of objective deficits alone and then to specify the presence or absence of risk factors such as SCC, functional impairment, vascular disease and biological markers. Indeed, given adequate data a risk calculator might be possible akin to that already used to calculate cardiovascular risk [20].

There has been a great deal of useful research on SCC and MCI in the last 10 years, but no very large naturalistic studies that would allow accurate risk profiling, although such studies are underway. There have also been no studies examining how well SCC would differentiate those with MCI from those with depression, anxiety or other causes of cognitive complaints. Finally we have almost no information on the relative risk of different types of cognitive complaint, e.g. difficulties in memory compared with word-finding difficulty. Future studies on MCI should specify the degree and nature of both subjective and objective memory complaints.


    Key points
 Top
 Abstract
 How many health elderly...
 How is the prevalence...
 How is the prognosis...
 How should SCC be...
 Conclusion
 Key points
 References
 

  • MCI is a condition of mixed aetiology which leads to dementia in about half of cases.
  • Many but not all individuals with MCI report subjective cognitive difficulties.
  • Otherwise healthy individuals with mild cognitive complaints are unlikely to be at high risk of future decline.
  • A combination of subjective and objective deficits is a cause for concern.


    References
 Top
 Abstract
 How many health elderly...
 How is the prevalence...
 How is the prognosis...
 How should SCC be...
 Conclusion
 Key points
 References
 

  1. Jessen F, Wiese B, Cvetanovska GE, et al. Patterns of subjective memory impairment in the elderly: association with memory performance. Psychol Med (2007) 37:1753–62.[Web of Science][Medline]
  2. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 256:240–6.[CrossRef][Web of Science][Medline]
  3. Portet F, Ousset PJ, Visser PJ, et al, Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. J Neurol Neurosurg Psychiatry (2006) 77:714–8.[Abstract/Free Full Text]
  4. Jonker C, Geerlings MI, Schmand B. Are memory complaints predictive for dementia? A review of clinical and population-based studies. Int J Geriatr Psychiatry (2000) 15:983–91.[CrossRef][Web of Science][Medline]
  5. Farias ST, Mungas D, Jagust W. Degree of discrepancy between self and other-reported everyday functioning by cognitive status: dementia, mild cognitive impairment, and healthy elders. Int J Geriatr Psychiatry (2005) 20:827–34.[CrossRef][Web of Science][Medline]
  6. Bassett SS, Folstein MF. Memory complain, memory performance, and psychiatric diagnosis: a community study. J Geriatr Psychiatry Neurol (1993) 6:105–11.[Abstract/Free Full Text]
  7. Crooks VC, Buckwalter JG, Petitti DB, et al. Self-reported severe memory problems as a screen for cognitive impairment and dementia. Dementia (2005) 4:539–51.[Abstract]
  8. Ganguli M, Dodge HH, Shen V, et al. Mild cognitive impairment, amnestic type An epidemiologic study. Neurology (2004) 63:115–21.[Abstract/Free Full Text]
  9. Purser JL, Fillenbaum GG, Wallace RB. Memory complaint is not necessary for diagnosis of mild cognitive impairment and does not predict 10-year trajectories of functional disability, word recall, or short portable mental status questionnaire limitations. J Am Geriatr Soc (2006) 54:335–8.[CrossRef][Web of Science][Medline]
  10. Luck T, Riedel-Heller SG, Kaduszkiewicz H, et al. Mild cognitive impairment in general practice: Age-specific prevalence and correlate results from the German study on ageing, cognition and dementia in primary care patients (AgeCoDe). Dement Geriatr Cogn Disord (2007) 24:307–16.[Web of Science][Medline]
  11. Geerlings MI, Jonker C, Bouter LM, et al. Association between memory complaints incident Alzheimer's Disease in elderly people with normal baseline cognition. Am J Psychiatry (1999) 156:531–7.[Abstract/Free Full Text]
  12. Bowen J, Teri L, Kukull W, et al. Progression to dementia in patients with isolated memory loss. Lancet (1997) 349:763–5.[CrossRef][Web of Science][Medline]
  13. Fisk JD, Merry HR, Rockwood K. Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology (2003) 61:1179–84.[Abstract/Free Full Text]
  14. Palmer K, Backman L, Winblad B, et al. Early symptoms and signs of cognitive de cits might not always be detectable in persons who develop Alzheimer's disease. Int Psychogeriatr (2008) 2:252–8.
  15. Grut M, Jorm Af, Fratiglioni L, et al. Memory complaints of elderly people in a population survey—variation according to dementia stage and depression. J Am Geriatr Soc (1993) 41:1295–300.[Web of Science][Medline]
  16. Clamette RM, Almeida OP, Forstl H, et al. Clinical characteristics of individuals with subjective memory loss in western Australia: results from a cross-sectional survey. Int J Geriatr Psychiatry (2001) 16:168–74.[CrossRef][Web of Science][Medline]
  17. Lautenschlager NT, Flicker L, Vasikaran S, et al. Subjective memory complaints with and without objective memory impairment relationship with risk factors for dementia. Am J Geriatr Psychiatry (2005) 13:731–4.[CrossRef][Web of Science][Medline]
  18. Lavery LL, Lu SY, Chang CCH, et al. Cognitive assessment of older primary care patients with and without memory complaints. J Gen Intern Med (2007) 22:949–54.[CrossRef][Web of Science][Medline]
  19. Jansen APD, van Hout HPJ, Nijpels G, et al. Yield of a new method to detect cognitive impairment in general practice. Int J Geriatr Psychiatry (2007) 22:590–7.[CrossRef][Web of Science][Medline]
  20. Pocock SJ, McCormack V, Gueyffier F. A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ (2001) 323:75–81.[Abstract/Free Full Text]
Received 14 February 2008; accepted in revised form 5 June 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
37/5/497    most recent
afn147v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mitchell, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitchell, A. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?